Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapy
Félix Pham, Marion Dufeu, Valentin Benboubker, Maxime Grimont et autres
0 citationsJournal for ImmunoTherapy of Cancer
Justine Berthet
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
49Publications signalées
434Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesOvarian cancer diagnosis and treatmentCAR-T cell therapy researchEndometrial and Cervical Cancer Treatments
Publications récentes
Specific dendritic cells spatial organization is associated to ICB Response in Non–Small-Cell Lung Cancer
Elisa GOBBINI, Pierre Duplouye, Miguel Hurtado, Anne‐Claire Doffin et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial
Isabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, Aymeric de Montfort et autres
4 citationsNature Communications
IntegrAlign: a comprehensive tool for multi-immunofluorescence panel integration through image alignment
Léo Hermet, Léo Laoubi, Martial Scavino, Anne‐Claire Doffin et autres
0 citationsBioinformatics
Data from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial
L. Collet, Maude Ardin, David Venet, Justine Berthet et autres
0 citations
Supplementary Methods 1 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial
L. Collet, Maude Ardin, David Venet, Justine Berthet et autres
0 citations
Supplementary Figure 3 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial
L. Collet, Maude Ardin, David Venet, Justine Berthet et autres
0 citations
Supplementary Figure 2 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial
L. Collet, Maude Ardin, David Venet, Justine Berthet et autres
0 citations
Supplementary Figure 6 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial
L. Collet, Maude Ardin, David Venet, Justine Berthet et autres
0 citations
Supplementary Figure 4 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial
L. Collet, Maude Ardin, David Venet, Justine Berthet et autres
0 citations
Supplementary Figure 5 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial
L. Collet, Maude Ardin, David Venet, Justine Berthet et autres
0 citations
Supplementary Table 1 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial
L. Collet, Maude Ardin, David Venet, Justine Berthet et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.